Patents by Inventor David John Bassin

David John Bassin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10974000
    Abstract: Methods and apparatus treat a respiratory disorder. For example, a pressure generator supplies a flow of air at positive pressure to a patient's airway through a patient interface. A sensor generates a signal representing respiratory flow rate of the patient. A controller controls the pressure generator to provide to the patient interface a ventilation therapy having a base pressure. The controller computes a measure of ventilation of the patient from the signal. The controller computes a measure of flow limitation from an inspiratory portion of the signal. The controller computes a ratio of the measure of ventilation and an expected normal ventilation. The controller adjusts a set point for the base pressure of the ventilation therapy based on the measure of flow limitation. The adjustment may further depend on a comparison between the ratio and a relative ventilation threshold that increases as the measure of flow limitation increases.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: April 13, 2021
    Inventor: David John Bassin
  • Patent number: 10967141
    Abstract: A ventilator device delivers ventilatory support to a patient in a back up timed mode when patient respiration is not detected or a spontaneous mode when patient respiration is detected. The timing threshold governing the back-up mode is chosen to deviate from normal expected respiration time for the patient to promote patient initiated ventilation in the spontaneous mode but permit back-up ventilation in the event of apnea. Automated adjustments to the timing threshold during the timed mode are made from the less vigilant timing threshold to a more vigilant threshold at or near a timing of normal expected breathing of the patient. Such adjustments may be made from a minimum to a maximum vigilance timing settings or incrementally there between as a function of time in the timed mode which is preferably the number of delivered machine breaths.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: April 6, 2021
    Inventor: David John Bassin
  • Publication number: 20210093812
    Abstract: Disclosed is an apparatus for treating a respiratory disorder, configured to compute a measure of typical recent ventilation such that a rate of adjustment of the measure of typical recent ventilation is reduced as a measure of recent uncompensated leak increases. Also disclosed is an apparatus for treating a respiratory disorder, configured to compute a target ventilation from a product of a measure of typical recent ventilation and a target fraction, wherein the target fraction is dependent on the recent pressure support.
    Type: Application
    Filed: September 10, 2020
    Publication date: April 1, 2021
    Applicant: ResMed Pty Ltd
    Inventor: David John Bassin
  • Patent number: 10940283
    Abstract: A comfortable low-leak mask assembly for use with Non-Invasive Positive Pressure Ventilation (NIPPV) is provided to improve patient compliance and/or treatment. The mask system may include headgear having straps that are substantially inextensible and/or micro-adjustable; and/or a mask and/or cushion that includes various structures to allow enhanced/tailored sealing and/or fit at selected locations on the patient's face.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: March 9, 2021
    Assignee: ResMed Pty Ltd
    Inventors: Michael Berthon-Jones, Michael Kassipillai Gunaratnam, Richard Sokolov, Robin Garth Hitchcock, David John Bassin, Gordon Joseph Malouf, Peter Edward Bateman, Philip Rodney Kwok
  • Patent number: 10918329
    Abstract: Methods and apparatus are disclosed for determining the occurrence of a closed or open apnea. Respiratory air flow from a patient is measured to give an air flow signal. The determination of an apnea is performed by applying an oscillatory pressure waveform of known frequency to a patient's airway, calculating a complex quantity representing a patient admittance (12) and comparing its value with ranges (14, 16) indicative of open or closed apneas. The method distinguishes open from closed apneas even when the model used to calculate admittance is not based on details of the respiratory apparatus. In addition the patient admittance may be compared with admittance during normal breathing to avoid having to characterize the airway.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: February 16, 2021
    Inventors: David John Bassin, John David Oates, Ronald James Huby, Benriah Goeldi
  • Publication number: 20210008311
    Abstract: A ventilator that delivers air at different pressures to a patient during inspiratory and expiratory cycles of breathing and that cycles from inspiratory to expiratory operation when the patient's respiratory flow passes a threshold level. The threshold generally increases from the beginning of inspiration to the end of inspiration. The increase can be linear over all or only a portion of the inspiratory cycle, and the threshold can be adjusted so that cycling is prevented during the initial portion of an inspiratory cycle. The minimum and maximum levels may both be functions of peak flow and the threshold may increase as a function of elapsed inspiratory time. The rate at which the threshold increases from a minimum level to a maximum level may be adjustable for individual patient needs and may be determined from previous breaths.
    Type: Application
    Filed: July 17, 2020
    Publication date: January 14, 2021
    Applicant: ResMed Pty Ltd
    Inventor: David John BASSIN
  • Patent number: 10856802
    Abstract: Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with Obstructive Sleep Disorder. Treatment may also be implemented by delivering synchronized cardiac pressure oscillations superimposed on a respiratory pressure level to provide assistance for the heart. Heart treatment pressure dose indicator may be calculated for prescribing and monitoring the delivery of treatment. The apparatus may also generate data to track heart failure condition that may be indicative of the degree of severity of heart failure based upon breathing patterns to assist in the diagnosis and management of heart failure patients.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: December 8, 2020
    Inventors: Anthony John Ujhazy, Jonathan Caldwell Wright, Glenn Richards, David John Bassin, Michael Berthon-Jones
  • Publication number: 20200368467
    Abstract: A respiratory treatment apparatus and method in which a leak is determined by using an averaging window. The window starts at the present time and extends back in time to a point determined according to a current one of progressively detected phase measures of a first respiratory cycle and a corresponding phase measure attributable to a preceding second respiratory cycle. In another aspect, a jamming index indicates whether the leak is rapidly changing. To the extent that jamming is high, the leak estimate used progressively changes from that using sliding breath-window averaging to a more robust and faster responding low-pass filter method, and adjustment of ventilatory support based on measures employing estimated respiratory flow is slowed down or stopped.
    Type: Application
    Filed: May 6, 2020
    Publication date: November 26, 2020
    Applicant: ResMed Pty Ltd,
    Inventor: David John BASSIN
  • Publication number: 20200368465
    Abstract: Systems slow breathing with positive pressure therapy. In embodiments, a current interim breathing rate target is set, and periodically magnitude of a variable pressure waveform scaled to the current interim breathing rate target is increased if breathing rate is greater than the interim rate target to lengthen breath duration. The magnitude of the pressure increase may be a function of the difference between the interim rate target and the breathing rate. The interim rate target may be reduced in response to slowing breathing rate. The waveform cycles, inhalation to exhalation, when airflow decreases to a cycle threshold. Different interim rate targets have different cycle threshold functions that allow easier cycling as the interim rate targets decrease. Similarly, the waveform triggers, exhalation to inhalation, when airflow increases to a trigger threshold. Different interim rate targets have different trigger threshold functions that allow easier triggering as the interim rate targets decrease.
    Type: Application
    Filed: April 10, 2020
    Publication date: November 26, 2020
    Applicant: ResMed Pty Ltd
    Inventors: Dion Charles Chewe Martin, David John Bassin
  • Publication number: 20200330708
    Abstract: An apparatus to generate pressure support ventilation and a method to control pressure support ventilation. The apparatus comprises: at least one sensor adapted to measure at least one respiratory parameter; a flow generator adapted for coupling with a patient respiratory interface; and a controller, coupled to the at least one sensor and the flow generator. The flow generator is configured to provide a flow of breathable gas for pressure support ventilation to the patient respiratory interface. The controller is configured to control the pressure support ventilation with the flow generator. The controller is further configured with a rest mode and an exercise mode. The rest mode comprises a first value set of control parameters for the pressure support ventilation and the exercise mode comprises a second value set of control parameters for the pressure support ventilation.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 22, 2020
    Applicant: ResMed Pty Ltd
    Inventors: Klaus Henry SCHINDHELM, Gordon Joseph Malouf, Steven Paul Farrugia, Clancy John Dennis, Michael Berthon-Jones, David John Bassin, Helmut Teschler
  • Patent number: 10751491
    Abstract: A ventilator that delivers air at different pressures to a patient during inspiratory and expiratory cycles of breathing and that cycles from inspiratory to expiratory operation when the patient's respiratory flow passes a threshold level. The threshold generally increases from the beginning of inspiration to the end of inspiration. The increase can be linear over all or only a portion of the inspiratory cycle, and the threshold can be adjusted so that cycling is prevented during the initial portion of an inspiratory cycle. The minimum and maximum levels may both be functions of peak flow and the threshold may increase as a function of elapsed inspiratory time. The rate at which the threshold increases from a minimum level to a maximum level may be adjustable for individual patient needs and may be determined from previous breaths.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: August 25, 2020
    Assignee: ResMed Pty Ltd
    Inventor: David John Bassin
  • Publication number: 20200254199
    Abstract: A ventilator device delivers ventilatory support to a patient in a back up timed mode when patient respiration is not detected or a spontaneous mode when patient respiration is detected. The timing threshold governing the back-up mode is chosen to deviate from normal expected respiration time for the patient to promote patient initiated ventilation in the spontaneous mode but permit back-up ventilation in the event of apnea. Automated adjustments to the timing threshold during the timed mode are made from the less vigilant timing threshold to a more vigilant threshold at or near a timing of normal expected breathing of the patient. Such adjustments may be made from a minimum to a maximum vigilance timing settings or incrementally there between as a function of time in the timed mode which is preferably the number of delivered machine breaths.
    Type: Application
    Filed: December 12, 2019
    Publication date: August 13, 2020
    Applicant: ResMed Pty Ltd
    Inventor: David John BASSIN
  • Publication number: 20200197640
    Abstract: A respiratory flow limitation detection device, which can include an airway pressure treatment generator, determines a flow limitation measure 506 based one or more shape indices for detecting partial obstruction and a measure of a patient's ventilation or respiratory duty cycle. The shape indices may be based on function(s) that ascertain the likelihood of the presence of M-shaped breathing patterns and/or chair-shaped breathing patterns. The measure of ventilation may be based on analysis of current and prior tidal volumes to detect a less than normal patient ventilation. The duty cycle measure may be a ratio of current and prior measures of inspiratory time to respiratory cycle time to detect an increase in the patient's inspiratory cycle time relative to the respiratory cycle time. A pressure setting based on the flow limitation may then be used to adjust the treatment pressure to ameliorate the patient's detected flow limitation condition.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 25, 2020
    Applicant: ResMed Pty Ltd
    Inventors: Jeffrey Peter ARMITSTEAD, Peter Edward BATEMAN, David John BASSIN
  • Patent number: 10688263
    Abstract: A servoventilator control slowly changes the target ventilation over a period of time, according to a preprogrammed schedule adapted to be set by the physician. Preferably, the target ventilation stays constant at an initial target ventilation for an initial hold time, and then increases at a constant rate until it reaches a final target ventilation, whereupon it stays constant thereafter. If the pressure support level is too high, possibly indicating glottic or upper airway closure, the rate of increase of target ventilation may be lowered or the final target ventilation not reached.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: June 23, 2020
    Assignee: ResMed Pty Ltd
    Inventor: David John Bassin
  • Patent number: 10675424
    Abstract: A respiratory treatment apparatus and method in which a leak is determined by using an averaging window. The window starts at the present time and extends back in time to a point determined according to a current one of progressively detected phase measures of a first respiratory cycle and a corresponding phase measure attributable to a preceding second respiratory cycle. In another aspect, a jamming index indicates whether the leak is rapidly changing. To the extent that jamming is high, the leak estimate used progressively changes from that using sliding breath-window averaging to a more robust and faster responding low-pass filter method, and adjustment of ventilatory support based on measures employing estimated respiratory flow is slowed down or stopped.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: June 9, 2020
    Assignee: ResMed Pty Ltd
    Inventor: David John Bassin
  • Patent number: 10668237
    Abstract: An apparatus to generate pressure support ventilation and a method to control pressure support ventilation. The apparatus comprises: at least one sensor adapted to measure at least one respiratory parameter; a flow generator adapted for coupling with a patient respiratory interface; and a controller, coupled to the at least one sensor and the flow generator. The flow generator is configured to provide a flow of breathable gas for pressure support ventilation to the patient respiratory interface. The controller is configured to control the pressure support ventilation with the flow generator. The controller is further configured with a rest mode and an exercise mode. The rest mode comprises a first value set of control parameters for the pressure support ventilation and the exercise mode comprises a second value set of control parameters for the pressure support ventilation.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: June 2, 2020
    Assignee: ResMed Pty Ltd
    Inventors: Klaus Henry Schindhelm, Gordon Joseph Malouf, Steven Paul Farrugia, Clancy John Dennis, Michael Berthon-Jones, David John Bassin, Helmut Teschler
  • Patent number: 10646670
    Abstract: Systems slow breathing with positive pressure therapy. In embodiments, a current interim breathing rate target is set, and periodically magnitude of a variable pressure waveform scaled to the current interim breathing rate target is increased if breathing rate is greater than the interim rate target to lengthen breath duration. The magnitude of the pressure increase may be a function of the difference between the interim rate target and the breathing rate. The interim rate target may be reduced in response to slowing breathing rate. The waveform cycles, inhalation to exhalation, when airflow decreases to a cycle threshold. Different interim rate targets have different cycle threshold functions that allow easier cycling as the interim rate targets decrease. Similarly, the waveform triggers, exhalation to inhalation, when airflow increases to a trigger threshold. Different interim rate targets have different trigger threshold functions that allow easier triggering as the interim rate targets decrease.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: May 12, 2020
    Assignee: ResMed Pty Ltd
    Inventors: Dion Charles Chewe Martin, David John Bassin
  • Patent number: 10549053
    Abstract: A respiratory flow limitation detection device, which can include an airway pressure treatment generator, determines a flow limitation measure 506 based one or more shape indices for detecting partial obstruction and a measure of a patient's ventilation or respiratory duty cycle. The shape indices may be based on function(s) that ascertain the likelihood of the presence of M-shaped breathing patterns and/or chair-shaped breathing patterns. The measure of ventilation may be based on analysis of current and prior tidal volumes to detect a less than normal patient ventilation. The duty cycle measure may be a ratio of current and prior measures of inspiratory time to respiratory cycle time to detect an increase in the patient's inspiratory cycle time relative to the respiratory cycle time. A pressure setting based on the flow limitation may then be used to adjust the treatment pressure to ameliorate the patient's detected flow limitation condition.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: February 4, 2020
    Assignee: ResMed Pty Ltd
    Inventors: Jeffrey Peter Armitstead, Peter Edward Bateman, David John Bassin
  • Patent number: 10537279
    Abstract: A method of operating a CPAP apparatus in which the interface pressure is controlled to rapidly drop at the start of expiration by an expiratory relief pressure (ERP) that is independent of instantaneous respiratory flow, following which the pressure rises to an inspiratory level at or shortly before the end of expiration, or at the onset of an expiratory pause, if any. The ERP is an increasing function of the inspiratory pressure. The expiratory pressure follows a template that is a function of the expected expiration time, the magnitude of the template being equal to the ERP. The current estimated proportion of expiration is determined by comparing the expiration time of the breath in progress to low-pass filtered expiratory durations measured for a number of the preceding breaths.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: January 21, 2020
    Assignee: ResMed Pty Ltd
    Inventor: David John Bassin
  • Publication number: 20200009338
    Abstract: A method and apparatus for providing ventilatory assistance to a spontaneously breathing patient an error signal (56) is computed that is the difference between a function of respiratory airflow (54) over a period of time and a target value (52). Using a servo loop, air is delivered to the patient at a pressure that is a function of the error signal, the phase of the current breathing cycle, and a loop gain that varies depending on the magnitude of the error signal. The loop gain increases with the magnitude of the error signal, and the gain is greater for error signals below a ventilation target than for error signals above the ventilation target value. The target value (52) is an alveolar ventilation that takes into account the patient's physiologic dead space.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 9, 2020
    Applicant: ResMed Pty Ltd
    Inventor: David John BASSIN